Keyphrases
Myosin
100%
Omecamtiv Mecarbil
100%
Cardiac Inotrope
100%
Positive Cardiac
100%
Working Stroke
100%
Actin
14%
Inhibitory Action
14%
Therapeutic Agents
14%
Phase III Clinical Trial
14%
Single Molecule
14%
Heart Failure Treatment
14%
Detachment Rate
14%
Force Output
14%
Cardiac Myosin
14%
Cardiac Performance
14%
Thin Layer Activation
14%
Applied Load
14%
Muscle Activation
14%
Myosin Molecule
14%
Myosin Activator
14%
ATP Concentration
14%
Actomyosin
14%
Selective Suppression
14%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
Adenosine Triphosphate
100%
Actin
100%
Myosin ATPase
100%
Heart Performance
100%
Pharmacology, Toxicology and Pharmaceutical Science
Inotropic Agent
100%
Omecamtiv Mecarbil
100%
Cerebrovascular Accident
100%
Clinical Trial
14%
Adenosine Triphosphate
14%
Congestive Heart Failure
14%
Actin
14%
Myosin Adenosine Triphosphatase
14%
Cardiac Myosin
14%